As I eluded to in my summary message, Mr. James is doing everything possible to avoid utilizing dilution as a means of growing the company. With that said, he is looking for the best possible terms to borrow the funds as his first alternative. Cash flow should continue to grow quarter over quarter to help support the company, but there could come a time when he may have to utilize a minimal amount of dilution, but only if he is left with no other alternative in the short term.
Mr. James and his management team are also making some sacrifices of their own during this transition phase, by keeping their salaries under $150k per year this growth stage. Only 3 of them are taking a salary of around $150k per year, while the rest is taking less than that amount. Those are meager salaries when living in the New York area where the cost living is very high.
Mr. James is very anxious to get started with the cannabis supplements and this Inaugural Scientific/Medical Advisory Board Meeting scheduled for next week will get the ball rolling. As seen previously, since taking over as CEO, Mr. James is not one to drag his feet. He has proved by example that he gets things done very rapidly. Just look how fast he took his idea to create Martha Stewart Essentials and make it into a reality!
I have no doubt that these cannabis supplements will be introduced into the market in very near future, but not until the experts agree on a formulation for indication they are seeking. It is absolutely critical that they have this participation and endorsement from the top experts in the field, something none of the other cannabis companies are taking the time to do. This will put their products above all others, by producing a cannabis supplement that will live up to the claims made on the label and be trusted by the end user who requires these supplements for their ailments. They may not be the first to introduce these supplements to the market, but they will be introducing the best with a one of a kind endorsement from the medical and scientific community who have studied and worked in this field for many years! Because of this, I am continuing to accumulate many more shares! I think this will have a huge impact on the business and NRTI's share price, not to mention TRTC's share price also.
If it requires a conservative amount dilution to make it happen, I won't be disappointed by any means. Most OTC companies at this stage would have diluted shareholders 10 fold by now, whereas, NRTI's CEO, Michael James, has sought out funds outside of dilution to support and grow the company, that was in excess of $5 million dollars so far, in government grants. He may very well do the same again, if available. If not, I will know that he has the shareholders in mind when making these decisions. He has proven that in the last two years. Mr. James speaks volumes by way of actions, not words. I expect the same as we move ahead with the development of these proven high quality, medically and scientifically endorsed, cannabis supplements!
Cheers!
.PNG)
AI
.PNG)
